BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Rajabi M, Mousa SA. The Role of Angiogenesis in Cancer Treatment. Biomedicines 2017;5:E34. [PMID: 28635679 DOI: 10.3390/biomedicines5020034] [Cited by in Crossref: 188] [Cited by in F6Publishing: 150] [Article Influence: 37.6] [Reference Citation Analysis]
Number Citing Articles
1 Makhov P, Joshi S, Ghatalia P, Kutikov A, Uzzo RG, Kolenko VM. Resistance to Systemic Therapies in Clear Cell Renal Cell Carcinoma: Mechanisms and Management Strategies. Mol Cancer Ther 2018;17:1355-64. [PMID: 29967214 DOI: 10.1158/1535-7163.MCT-17-1299] [Cited by in Crossref: 54] [Cited by in F6Publishing: 49] [Article Influence: 18.0] [Reference Citation Analysis]
2 Zhang Z, Tan X, Luo J, Cui B, Lei S, Si Z, Shen L, Yao H. GNA13 promotes tumor growth and angiogenesis by upregulating CXC chemokines via the NF-κB signaling pathway in colorectal cancer cells. Cancer Med 2018;7:5611-20. [PMID: 30267476 DOI: 10.1002/cam4.1783] [Cited by in Crossref: 21] [Cited by in F6Publishing: 17] [Article Influence: 5.3] [Reference Citation Analysis]
3 Sun Z, Velázquez-Quesada I, Murdamoothoo D, Ahowesso C, Yilmaz A, Spenlé C, Averous G, Erne W, Oberndorfer F, Oszwald A, Kain R, Bourdon C, Mangin P, Deligne C, Midwood K, Abou-Faycal C, Lefebvre O, Klein A, van der Heyden M, Chenard MP, Christofori G, Mathelin C, Loustau T, Hussenet T, Orend G. Tenascin-C increases lung metastasis by impacting blood vessel invasions.Matrix Biol. 2019;83:26-47. [PMID: 31288084 DOI: 10.1016/j.matbio.2019.07.001] [Cited by in Crossref: 26] [Cited by in F6Publishing: 25] [Article Influence: 8.7] [Reference Citation Analysis]
4 Yao L, Li Y, Chen H, Wen X, Pang Y, Chen Z, Guo Z, Zhang X, Wu H, Guo W. Dual Targeting of Integrin αvβ3 and Neuropilin-1 Receptors Improves Micropositron Emission Tomography Imaging of Breast Cancer. Mol Pharm 2022. [PMID: 35414180 DOI: 10.1021/acs.molpharmaceut.1c01015] [Reference Citation Analysis]
5 Bayat N, Izadpanah R, Ebrahimi-Barough S, Norouzi Javidan A, Ai A, Mokhtari Ardakan MM, Saberi H, Ai J. The Anti-Angiogenic Effect of Atorvastatin in Glioblastoma Spheroids Tumor Cultured in Fibrin Gel: in 3D in Vitro Model. Asian Pac J Cancer Prev 2018;19:2553-60. [PMID: 30256055 DOI: 10.22034/APJCP.2018.19.9.2553] [Cited by in F6Publishing: 4] [Reference Citation Analysis]
6 Adil MS, Khulood D, Somanath PR. Targeting Akt-associated microRNAs for cancer therapeutics. Biochem Pharmacol 2021;189:114384. [PMID: 33347867 DOI: 10.1016/j.bcp.2020.114384] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
7 Chiodelli P, Urbinati C, Paiardi G, Monti E, Rusnati M. Sialic acid as a target for the development of novel antiangiogenic strategies. Future Med Chem 2018;10:2835-54. [PMID: 30539670 DOI: 10.4155/fmc-2018-0298] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 2.8] [Reference Citation Analysis]
8 Griffiths JI, Cohen AL, Jones V, Salgia R, Chang JT, Bild AH. Opportunities for improving cancer treatment using systems biology. Curr Opin Syst Biol 2019;17:41-50. [PMID: 32518857 DOI: 10.1016/j.coisb.2019.10.018] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
9 Wang X, Bove AM, Simone G, Ma B. Molecular Bases of VEGFR-2-Mediated Physiological Function and Pathological Role. Front Cell Dev Biol 2020;8:599281. [PMID: 33304904 DOI: 10.3389/fcell.2020.599281] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
10 Escobar-puentes AA, Palomo I, Rodríguez L, Fuentes E, Villegas-ochoa MA, González-aguilar GA, Olivas-aguirre FJ, Wall-medrano A. Sweet Potato (Ipomoea batatas L.) Phenotypes: From Agroindustry to Health Effects. Foods 2022;11:1058. [DOI: 10.3390/foods11071058] [Reference Citation Analysis]
11 Oh M, Rho SB, Son C, Park K, Song SY. Non-proteolytic calpain-6 interacts with VEGFA and promotes angiogenesis by increasing VEGF secretion. Sci Rep 2019;9:15771. [PMID: 31673071 DOI: 10.1038/s41598-019-52364-6] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
12 Soliman MA, Guccione J, Reiter AM, Moawad AW, Etchison A, Kamel S, Khatchikian AD, Elsayes KM. Current Concepts in Multi-Modality Imaging of Solid Tumor Angiogenesis. Cancers (Basel) 2020;12:E3239. [PMID: 33153067 DOI: 10.3390/cancers12113239] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
13 Khodabakhsh F, Merikhian P, Eisavand MR, Farahmand L. Crosstalk between MUC1 and VEGF in angiogenesis and metastasis: a review highlighting roles of the MUC1 with an emphasis on metastatic and angiogenic signaling. Cancer Cell Int 2021;21:200. [PMID: 33836774 DOI: 10.1186/s12935-021-01899-8] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
14 Gharib AF, Elsawy WH, Alrehaili AA, Amin HS, Alhuthali HM, Bakhuraysah MM, El Askary A, Koundal D. The Application of Molecular Techniques for Assessment of SOX2 and miR126 Expression as Prognostic Markers in Esophageal Carcinoma. Computational and Mathematical Methods in Medicine 2022;2022:1-6. [DOI: 10.1155/2022/1514412] [Reference Citation Analysis]
15 Crucitta S, Restante G, Del Re M, Bertolini I, Bona E, Rofi E, Fontanelli L, Gianfilippo G, Fogli S, Stasi I, Ghilli M, Fontana A, Danesi R. Endothelial nitric oxide synthase c.-813C>T predicts for proteinuria in metastatic breast cancer patients treated with bevacizumab-based chemotherapy. Cancer Chemother Pharmacol 2019;84:1219-27. [PMID: 31529205 DOI: 10.1007/s00280-019-03933-z] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
16 Luo J, Xie K, Gao X, Yao Y, Wang G, Shao C, Li X, Xu Y, Ren B, Hu L, Shen Y. Long Noncoding RNA Nuclear Paraspeckle Assembly Transcript 1 Promotes Progression and Angiogenesis of Esophageal Squamous Cell Carcinoma Through miR-590-3p/MDM2 Axis. Front Oncol 2020;10:618930. [PMID: 33680941 DOI: 10.3389/fonc.2020.618930] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
17 Pauli FP, Martins JR, Paschoalin T, Ionta M, Barbosa MLC, Barreiro EJ. Novel VEGFR‐2 inhibitors with an N ‐acylhydrazone scaffold. Arch Pharm 2020;353:2000130. [DOI: 10.1002/ardp.202000130] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
18 Hu Z, Sun S, Zhao X, Yu H, Wu X, Wang J, Chang J, Wang H. Rh-Endostatin Plus Irinotecan/Cisplatin as Second-Line Therapy for Advanced Esophageal Squamous Cell Carcinoma: An Open-Label, Phase II Study. The Oncologist 2022;27:253-e312. [DOI: 10.1093/oncolo/oyab078] [Reference Citation Analysis]
19 Amirinejad R, Rezaei M, Shirvani-Farsani Z. An update on long intergenic noncoding RNA p21: a regulatory molecule with various significant functions in cancer. Cell Biosci 2020;10:82. [PMID: 32582435 DOI: 10.1186/s13578-020-00445-9] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
20 Sethy C, Goutam K, Nayak D, Pradhan R, Molla S, Chatterjee S, Rout N, Wyatt MD, Narayan S, Kundu CN. Clinical significance of a pvrl 4 encoded gene Nectin-4 in metastasis and angiogenesis for tumor relapse. J Cancer Res Clin Oncol 2020;146:245-59. [DOI: 10.1007/s00432-019-03055-2] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 3.3] [Reference Citation Analysis]
21 Qin X, Chen C, Wang L, Chen X, Liang Y, Jin X, Pan W, Liu Z, Li H, Yang G. In-vivo 3D imaging of Zebrafish's intersegmental vessel development by a bi-directional light-sheet illumination microscope. Biochem Biophys Res Commun 2021;557:8-13. [PMID: 33857842 DOI: 10.1016/j.bbrc.2021.03.160] [Reference Citation Analysis]
22 Gong G, Zheng Y, Kong X, Wen Z. Anti-angiogenesis Function of Ononin via Suppressing the MEK/Erk Signaling Pathway. J Nat Prod 2021;84:1755-62. [PMID: 34029083 DOI: 10.1021/acs.jnatprod.1c00008] [Reference Citation Analysis]
23 Ruzic D, Djoković N, Srdić-rajić T, Echeverria C, Nikolic K, Santibanez JF. Targeting Histone Deacetylases: Opportunities for Cancer Treatment and Chemoprevention. Pharmaceutics 2022;14:209. [DOI: 10.3390/pharmaceutics14010209] [Reference Citation Analysis]
24 Watson N, Al-Samkari H. Thrombotic and bleeding risk of angiogenesis inhibitors in patients with and without malignancy. J Thromb Haemost 2021;19:1852-63. [PMID: 33928747 DOI: 10.1111/jth.15354] [Reference Citation Analysis]
25 Mao L, Xia L, Chang J, Liu J, Jiang L, Wu C, Fang B. The synergistic effects of Sr and Si bioactive ions on osteogenesis, osteoclastogenesis and angiogenesis for osteoporotic bone regeneration. Acta Biomaterialia 2017;61:217-32. [DOI: 10.1016/j.actbio.2017.08.015] [Cited by in Crossref: 101] [Cited by in F6Publishing: 92] [Article Influence: 20.2] [Reference Citation Analysis]
26 Leman JKH, Munoz-Erazo L, Kemp RA. The Intestinal Tumour Microenvironment. Adv Exp Med Biol 2020;1226:1-22. [PMID: 32030672 DOI: 10.1007/978-3-030-36214-0_1] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
27 Rajabi M, Godugu K, Sudha T, Bharali DJ, Mousa SA. Triazole Modified Tetraiodothyroacetic Acid Conjugated to Polyethylene Glycol: High Affinity Thyrointegrin α v β 3 Antagonist with Potent Anticancer Activities in Glioblastoma Multiforme. Bioconjugate Chem 2019;30:3087-97. [DOI: 10.1021/acs.bioconjchem.9b00742] [Cited by in Crossref: 14] [Cited by in F6Publishing: 10] [Article Influence: 4.7] [Reference Citation Analysis]
28 Zhu J, Yang Q, Xu W. Iterative Upgrading of Small Molecular Tyrosine Kinase Inhibitors for EGFR Mutation in NSCLC: Necessity and Perspective. Pharmaceutics 2021;13:1500. [PMID: 34575576 DOI: 10.3390/pharmaceutics13091500] [Reference Citation Analysis]
29 Rabelo ACS, Borghesi J, Noratto GD. The role of dietary polyphenols in osteosarcoma: A possible clue about the molecular mechanisms involved in a process that is just in its infancy. J Food Biochem 2021;:e14026. [PMID: 34873724 DOI: 10.1111/jfbc.14026] [Reference Citation Analysis]
30 Li X, Zhu X, Wang Y, Wang R, Wang L, Zhu ML, Zheng L. Prognostic value and association of Lauren classification with VEGF and VEGFR-2 expression in gastric cancer. Oncol Lett 2019;18:4891-9. [PMID: 31611999 DOI: 10.3892/ol.2019.10820] [Cited by in Crossref: 1] [Cited by in F6Publishing: 6] [Article Influence: 0.3] [Reference Citation Analysis]
31 Xu JW, Wang L, Cheng YG, Zhang GY, Hu SY, Zhou B, Zhan HX. Immunotherapy for pancreatic cancer: A long and hopeful journey. Cancer Lett 2018;425:143-51. [PMID: 29605510 DOI: 10.1016/j.canlet.2018.03.040] [Cited by in Crossref: 20] [Cited by in F6Publishing: 22] [Article Influence: 5.0] [Reference Citation Analysis]
32 Xin Y, Roh K, Cho E, Park D, Whang W, Jung E. Isookanin Inhibits PGE2-Mediated Angiogenesis by Inducing Cell Arrest through Inhibiting the Phosphorylation of ERK1/2 and CREB in HMEC-1 Cells. Int J Mol Sci 2021;22:6466. [PMID: 34208772 DOI: 10.3390/ijms22126466] [Reference Citation Analysis]
33 Lin X, Qiu W, Xiao Y, Ma J, Xu F, Zhang K, Gao Y, Chen Q, Li Y, Li H, Qian A. MiR-199b-5p Suppresses Tumor Angiogenesis Mediated by Vascular Endothelial Cells in Breast Cancer by Targeting ALK1. Front Genet 2019;10:1397. [PMID: 32082362 DOI: 10.3389/fgene.2019.01397] [Cited by in Crossref: 17] [Cited by in F6Publishing: 15] [Article Influence: 8.5] [Reference Citation Analysis]
34 Palethorpe HM, Tomita Y, Smith E, Pei JV, Townsend AR, Price TJ, Young JP, Yool AJ, Hardingham JE. The Aquaporin 1 Inhibitor Bacopaside II Reduces Endothelial Cell Migration and Tubulogenesis and Induces Apoptosis. Int J Mol Sci 2018;19:E653. [PMID: 29495367 DOI: 10.3390/ijms19030653] [Cited by in Crossref: 18] [Cited by in F6Publishing: 15] [Article Influence: 4.5] [Reference Citation Analysis]
35 Paris JL, Villaverde G, Gómez-Graña S, Vallet-Regí M. Nanoparticles for multimodal antivascular therapeutics: Dual drug release, photothermal and photodynamic therapy. Acta Biomater 2020;101:459-68. [PMID: 31706040 DOI: 10.1016/j.actbio.2019.11.004] [Cited by in Crossref: 26] [Cited by in F6Publishing: 21] [Article Influence: 8.7] [Reference Citation Analysis]
36 Chung SY, Chao TC, Su Y. The Stemness-High Human Colorectal Cancer Cells Promote Angiogenesis by Producing Higher Amounts of Angiogenic Cytokines via Activation of the Egfr/Akt/Nf-κB Pathway. Int J Mol Sci 2021;22:1355. [PMID: 33573006 DOI: 10.3390/ijms22031355] [Reference Citation Analysis]
37 Kargozar S, Baino F, Hamzehlou S, Hamblin MR, Mozafari M. Nanotechnology for angiogenesis: opportunities and challenges. Chem Soc Rev 2020;49:5008-57. [PMID: 32538379 DOI: 10.1039/c8cs01021h] [Cited by in Crossref: 28] [Cited by in F6Publishing: 9] [Article Influence: 14.0] [Reference Citation Analysis]
38 Yousefi M, Dehghani S, Nosrati R, Ghanei M, Salmaninejad A, Rajaie S, Hasanzadeh M, Pasdar A. Current insights into the metastasis of epithelial ovarian cancer - hopes and hurdles. Cell Oncol (Dordr) 2020;43:515-38. [PMID: 32418122 DOI: 10.1007/s13402-020-00513-9] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 5.0] [Reference Citation Analysis]
39 Lai CC, Chen TJ, Chan TC, Li WS, He HL. Prognostic significance of OXR1 in urothelial carcinoma: low OXR1 expression is associated with worse survival. Future Oncol 2021;17:4145-56. [PMID: 34467778 DOI: 10.2217/fon-2021-0184] [Reference Citation Analysis]
40 Youssef ASE, Abdel-fattah MA, Lotfy MM, Nassar A, Abouelhoda M, Touny AO, Hassan ZK, Mohey Eldin M, Bahnassy AA, Khaled H, Zekri ARN. Multigene Panel Sequencing Reveals Cancer-Specific and Common Somatic Mutations in Colorectal Cancer Patients: An Egyptian Experience. CIMB 2022;44:1332-52. [DOI: 10.3390/cimb44030090] [Reference Citation Analysis]
41 Li SJ, Chen JX, Sun ZJ. Improving antitumor immunity using antiangiogenic agents: Mechanistic insights, current progress, and clinical challenges. Cancer Commun (Lond) 2021. [PMID: 34137513 DOI: 10.1002/cac2.12183] [Reference Citation Analysis]
42 Richard S, Brun A, Tedesco A, Gallois B, Taghi N, Dantan P, Seguin J, Fleury V. Direct imaging of capillaries reveals the mechanism of arteriovenous interlacing in the chick chorioallantoic membrane. Commun Biol 2018;1:235. [PMID: 30588514 DOI: 10.1038/s42003-018-0229-x] [Reference Citation Analysis]
43 Dong Z, Abbas MN, Kausar S, Yang J, Li L, Tan L, Cui H. Biological Functions and Molecular Mechanisms of Antibiotic Tigecycline in the Treatment of Cancers. Int J Mol Sci 2019;20:E3577. [PMID: 31336613 DOI: 10.3390/ijms20143577] [Cited by in Crossref: 20] [Cited by in F6Publishing: 16] [Article Influence: 6.7] [Reference Citation Analysis]
44 Ong CP, Lee WL, Tang YQ, Yap WH. Honokiol: A Review of Its Anticancer Potential and Mechanisms. Cancers (Basel) 2019;12:E48. [PMID: 31877856 DOI: 10.3390/cancers12010048] [Cited by in Crossref: 32] [Cited by in F6Publishing: 24] [Article Influence: 10.7] [Reference Citation Analysis]
45 Gluszko A, Mirza SM, Piszczatowska K, Kantor I, Struga M, Szczepanski MJ. The role of tumor-derived exosomes in tumor angiogenesis and tumor progression. Current Issues in Pharmacy and Medical Sciences 2019;32:193-202. [DOI: 10.2478/cipms-2019-0034] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
46 Varghese JE, Balasubramanian B, Velayuthaprabhu S, Thirunavukkarasu V, Rengarajan RL, Murugesh E, Manikandan P, Arun M, Anand AV. Therapeutic effects of vitamin D and cancer: An overview. Food Frontiers 2021;2:417-25. [DOI: 10.1002/fft2.97] [Reference Citation Analysis]
47 Galon J, Bruni D. Approaches to treat immune hot, altered and cold tumours with combination immunotherapies. Nat Rev Drug Discov 2019;18:197-218. [PMID: 30610226 DOI: 10.1038/s41573-018-0007-y] [Cited by in Crossref: 655] [Cited by in F6Publishing: 653] [Article Influence: 218.3] [Reference Citation Analysis]
48 Skonieczna M, Adamiec M, Hudy D, Nieslon P, Fochtman D, Bil P. Live Impedance Measurements and Time-lapse Microscopy Observations of Cellular Adhesion, Proliferation and Migration after Ionizing Radiation. Curr Pharm Biotechnol 2020;21:642-52. [PMID: 31889493 DOI: 10.2174/1389201021666191224121206] [Reference Citation Analysis]
49 Schneider MK, Ioanas HI, Xandry J, Rudin M. An in vivo wound healing model for the characterization of the angiogenic process and its modulation by pharmacological interventions. Sci Rep 2019;9:6004. [PMID: 30979919 DOI: 10.1038/s41598-019-42479-1] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 1.3] [Reference Citation Analysis]
50 Pu Y, Jin P, Liu L, Pu Q, Wu F. Dysosma versipellis Extract Inhibits Esophageal Cancer Progression through the Wnt Signaling Pathway. Evid Based Complement Alternat Med 2021;2021:1221899. [PMID: 34729077 DOI: 10.1155/2021/1221899] [Reference Citation Analysis]
51 Kamble SS, Gacche RN. “Evaluation of anti-breast cancer, anti-angiogenic and antioxidant properties of selected medicinal plants”. European Journal of Integrative Medicine 2019;25:13-9. [DOI: 10.1016/j.eujim.2018.11.006] [Cited by in Crossref: 14] [Cited by in F6Publishing: 4] [Article Influence: 4.7] [Reference Citation Analysis]
52 Asgari HT, Es-haghi A, Karimi E. Anti-angiogenic, antibacterial, and antioxidant activities of nanoemulsions synthesized by Cuminum cyminum L. tinctures. Food Measure 2021;15:3649-59. [DOI: 10.1007/s11694-021-00947-1] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
53 Zapp C, Mundinger P, Boehm H. Natural Presentation of Glycosaminoglycans in Synthetic Matrices for 3D Angiogenesis Models. Front Cell Dev Biol 2021;9:729670. [PMID: 34671601 DOI: 10.3389/fcell.2021.729670] [Reference Citation Analysis]
54 Yan H, Bian A, Gao X, Li H, Chen Z, Liu X. Novel applications for an established antimalarial drug: tumoricidal activity of quinacrine. Future Oncology 2018;14:1511-20. [DOI: 10.2217/fon-2017-0728] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.5] [Reference Citation Analysis]
55 Iyer AS, Chapoval SP. Neuroimmune Semaphorin 4A in Cancer Angiogenesis and Inflammation: A Promoter or a Suppressor? Int J Mol Sci 2018;20:E124. [PMID: 30598022 DOI: 10.3390/ijms20010124] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 1.8] [Reference Citation Analysis]
56 Rani A, Dasgupta P, Murphy JJ. Prostate Cancer. The American Journal of Pathology 2019;189:2119-37. [DOI: 10.1016/j.ajpath.2019.07.007] [Cited by in Crossref: 22] [Cited by in F6Publishing: 20] [Article Influence: 7.3] [Reference Citation Analysis]
57 Nikmaneshi MR, Firoozabadi B, Mozafari A. Chemo-mechanistic multi-scale model of a three-dimensional tumor microenvironment to quantify the chemotherapy response of cancer. Biotechnol Bioeng 2021. [PMID: 34133020 DOI: 10.1002/bit.27863] [Reference Citation Analysis]
58 Farris MK, Helis CA, Hughes RT, Lecompte MC, Borg AM, Nieto K, Munley MT, Willey JS. Bench to Bedside: Animal Models of Radiation Induced Musculoskeletal Toxicity. Cancers 2020;12:427. [DOI: 10.3390/cancers12020427] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.5] [Reference Citation Analysis]
59 Aziz MNM, Rahim NFC, Hussin Y, Yeap SK, Masarudin MJ, Mohamad NE, Akhtar MN, Osman MA, Cheah YK, Alitheen NB. Anti-Metastatic and Anti-Angiogenic Effects of Curcumin Analog DK1 on Human Osteosarcoma Cells In Vitro. Pharmaceuticals (Basel) 2021;14:532. [PMID: 34204873 DOI: 10.3390/ph14060532] [Reference Citation Analysis]
60 Nawara HM, Afify SM, Hassan G, Zahra MH, Atallah MN, Seno A, Seno M. An assay for cancer stem cell-induced angiogenesis on chick chorioallantoic membrane. Cell Biol Int 2021;45:749-56. [PMID: 33274828 DOI: 10.1002/cbin.11511] [Reference Citation Analysis]
61 V Subramaniam A, Yehya AHS, Cheng WK, Wang X, Oon CE. Epigenetics: The master control of endothelial cell fate in cancer. Life Sci 2019;232:116652. [PMID: 31302197 DOI: 10.1016/j.lfs.2019.116652] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
62 Halkola AS, Aittokallio T, Parvinen K. Tumor microenvironment as a metapopulation model: the effects of angiogenesis, emigration and treatment modalities. J Theor Biol 2022;:111147. [PMID: 35489642 DOI: 10.1016/j.jtbi.2022.111147] [Reference Citation Analysis]
63 Chidambaram JSCA, Veerapandian B, Sarwareddy KK, Mani KP, Shanmugam SR, Venkatachalam P. Studies on solvent precipitation of levan synthesized using Bacillus subtilis MTCC 441. Heliyon 2019;5:e02414. [PMID: 31687543 DOI: 10.1016/j.heliyon.2019.e02414] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
64 Zengin M, Unsal Tan O, Arafa RK, Balkan A. Design and Synthesis of New 2-Oxoquinoxalinyl-1,2,4-triazoles as Antitumor VEGFR-2 Inhibitors. Bioorganic Chemistry 2022. [DOI: 10.1016/j.bioorg.2022.105696] [Reference Citation Analysis]
65 Jin Y, Cao J, Hu X, Cheng H. Long noncoding RNA TUG1 upregulates VEGFA to enhance malignant behaviors in stomach adenocarcinoma by sponging miR-29c-3p. J Clin Lab Anal 2021;:e24106. [PMID: 34762771 DOI: 10.1002/jcla.24106] [Reference Citation Analysis]
66 Singh S, Meena A, Luqman S. Baicalin mediated regulation of key signaling pathways in cancer. Pharmacol Res 2021;164:105387. [PMID: 33352232 DOI: 10.1016/j.phrs.2020.105387] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
67 Liu YX, Xu BW, Niu XD, Chen YJ, Fu XQ, Wang XQ, Yin CL, Chou JY, Li JK, Wu JY, Bai JX, Wu Y, Li SM, Yu ZL. Inhibition of Src/STAT3 signaling-mediated angiogenesis is involved in the anti-melanoma effects of dioscin. Pharmacol Res 2021;175:105983. [PMID: 34822972 DOI: 10.1016/j.phrs.2021.105983] [Reference Citation Analysis]
68 Larionova I, Kazakova E, Gerashchenko T, Kzhyshkowska J. New Angiogenic Regulators Produced by TAMs: Perspective for Targeting Tumor Angiogenesis. Cancers (Basel) 2021;13:3253. [PMID: 34209679 DOI: 10.3390/cancers13133253] [Reference Citation Analysis]
69 Wen SY, Cheng SY, Ng SC, Aneja R, Chen CJ, Huang CY, Kuo WW. Roles of p38α and p38β mitogen‑activated protein kinase isoforms in human malignant melanoma A375 cells. Int J Mol Med 2019;44:2123-32. [PMID: 31661126 DOI: 10.3892/ijmm.2019.4383] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
70 García-Martínez E, Redondo A, Piulats JM, Rodríguez A, Casado A. Are antiangiogenics a good 'partner' for immunotherapy in ovarian cancer? Angiogenesis 2020;23:543-57. [PMID: 32691290 DOI: 10.1007/s10456-020-09734-w] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
71 Ishikawa M, Osaki M, Uno N, Ohira T, Kugoh H, Okada F. MTA1, a metastasis‑associated protein, in endothelial cells is an essential molecule for angiogenesis. Mol Med Rep 2022;25:11. [PMID: 34779499 DOI: 10.3892/mmr.2021.12527] [Reference Citation Analysis]
72 Majnooni MB, Fakhri S, Smeriglio A, Trombetta D, Croley CR, Bhattacharyya P, Sobarzo-Sánchez E, Farzaei MH, Bishayee A. Antiangiogenic Effects of Coumarins against Cancer: From Chemistry to Medicine. Molecules 2019;24:E4278. [PMID: 31771270 DOI: 10.3390/molecules24234278] [Cited by in Crossref: 17] [Cited by in F6Publishing: 15] [Article Influence: 5.7] [Reference Citation Analysis]
73 Kuai J, Han C, Wei W. Potential Regulatory Roles of GRK2 in Endothelial Cell Activity and Pathological Angiogenesis. Front Immunol 2021;12:698424. [PMID: 34335610 DOI: 10.3389/fimmu.2021.698424] [Reference Citation Analysis]
74 Wang Y, Li Z, Mo F, Gu Z, Hu Q. Engineered platelets: Advocates for tumor immunotherapy. Nano Today 2021;40:101281. [DOI: 10.1016/j.nantod.2021.101281] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
75 Esteghlal S, Mokhtari MJ, Beyzaei Z. Quercetin Can Inhibit Angiogenesis via the Down Regulation of MALAT1 and MIAT LncRNAs in Human Umbilical Vein Endothelial Cells. Int J Prev Med 2021;12:59. [PMID: 34447501 DOI: 10.4103/ijpvm.IJPVM_103_20] [Reference Citation Analysis]
76 Ho YJ, Chang J, Yeh KT, Gong Z, Lin YM, Lu JW. Prognostic and Clinical Implications of WNK Lysine Deficient Protein Kinase 1 Expression in Patients With Hepatocellular Carcinoma. In Vivo 2020;34:2631-40. [PMID: 32871793 DOI: 10.21873/invivo.12081] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
77 Rieck S, Heun Y, Heidsieck A, Mykhaylyk O, Pfeifer A, Gleich B, Mannell H, Wenzel D. Local anti-angiogenic therapy by magnet-assisted downregulation of SHP2 phosphatase. J Control Release 2019;305:155-64. [PMID: 31121282 DOI: 10.1016/j.jconrel.2019.05.031] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
78 Melegh Z, Oltean S. Targeting Angiogenesis in Prostate Cancer. Int J Mol Sci. 2019;20. [PMID: 31151317 DOI: 10.3390/ijms20112676] [Cited by in Crossref: 27] [Cited by in F6Publishing: 29] [Article Influence: 9.0] [Reference Citation Analysis]
79 Duru G, van Egmond M, Heemskerk N. A Window of Opportunity: Targeting Cancer Endothelium to Enhance Immunotherapy. Front Immunol 2020;11:584723. [PMID: 33262763 DOI: 10.3389/fimmu.2020.584723] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
80 Terao R, Kaneko H. Lipid Signaling in Ocular Neovascularization. Int J Mol Sci 2020;21:E4758. [PMID: 32635437 DOI: 10.3390/ijms21134758] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
81 Giacomini A, Grillo E, Rezzola S, Ribatti D, Rusnati M, Ronca R, Presta M. The FGF/FGFR system in the physiopathology of the prostate gland. Physiol Rev 2021;101:569-610. [PMID: 32730114 DOI: 10.1152/physrev.00005.2020] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
82 Rajabi M, Yalcin M, Mousa SA. Synthesis of new analogs of tetraiodothyroacetic acid (tetrac) as novel angiogenesis inhibitors for treatment of cancer. Bioorganic & Medicinal Chemistry Letters 2018;28:1223-7. [DOI: 10.1016/j.bmcl.2018.02.045] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.8] [Reference Citation Analysis]
83 Mao C, Zeng X, Zhang C, Yang Y, Xiao X, Luan S, Zhang Y, Yuan Y. Mechanisms of Pharmaceutical Therapy and Drug Resistance in Esophageal Cancer. Front Cell Dev Biol 2021;9:612451. [PMID: 33644048 DOI: 10.3389/fcell.2021.612451] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
84 Loggenberg SR, Twilley D, De Canha MN, Meyer D, Mabena EC, Lall N. Evaluation of Wound Healing and Antibacterial Potential of Greyia radlkoferi Szyszyl. Ethanolic Leaf Extract. Front Pharmacol 2022;13:806285. [DOI: 10.3389/fphar.2022.806285] [Reference Citation Analysis]
85 de Oliveira DCS, de Freitas CF, Calori IR, Goncalves RS, Cardinali CAEF, Malacarne LC, Ravanelli MI, de Oliveira HPM, Tedesco AC, Caetano W, Hioka N, Tessaro AL. Theranostic verteporfin- loaded lipid-polymer liposome for photodynamic applications. J Photochem Photobiol B 2020;212:112039. [PMID: 33002779 DOI: 10.1016/j.jphotobiol.2020.112039] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
86 Shi A, Wang T, Jia M, Dong L, Shi H. Effects of SDF-1/CXCR7 on the Migration, Invasion and Epithelial-Mesenchymal Transition of Gastric Cancer Cells. Front Genet 2021;12:760048. [PMID: 34858476 DOI: 10.3389/fgene.2021.760048] [Reference Citation Analysis]
87 Kang B, Park H, Kim B. Anticancer Activity and Underlying Mechanism of Phytochemicals against Multiple Myeloma. Int J Mol Sci 2019;20:E2302. [PMID: 31075954 DOI: 10.3390/ijms20092302] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
88 Garrido A, Vera G, Delaye PO, Enguehard-Gueiffier C. Imidazo[1,2-b]pyridazine as privileged scaffold in medicinal chemistry: An extensive review. Eur J Med Chem 2021;226:113867. [PMID: 34607244 DOI: 10.1016/j.ejmech.2021.113867] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
89 Manso J, Pezzani R. New targeted therapies for adrenocortical carcinomas. Minerva Endocrinol 2019;44:70-81. [PMID: 29808641 DOI: 10.23736/S0391-1977.18.02860-2] [Reference Citation Analysis]
90 Mukherjee A, Madamsetty VS, Paul MK, Mukherjee S. Recent Advancements of Nanomedicine towards Antiangiogenic Therapy in Cancer. Int J Mol Sci 2020;21:E455. [PMID: 31936832 DOI: 10.3390/ijms21020455] [Cited by in Crossref: 24] [Cited by in F6Publishing: 19] [Article Influence: 12.0] [Reference Citation Analysis]
91 Stryker ZI, Rajabi M, Davis PJ, Mousa SA. Evaluation of Angiogenesis Assays. Biomedicines 2019;7:E37. [PMID: 31100863 DOI: 10.3390/biomedicines7020037] [Cited by in Crossref: 27] [Cited by in F6Publishing: 20] [Article Influence: 9.0] [Reference Citation Analysis]
92 Shan K, Lu T, Ji H, You X, Ren Y, Ding X, Sounthararaj RK, Jacob JA, Yang S. Inositol hexakisphosphate induces apoptosis, cell cycle arrest in non-Hodgkin’s Burkitt lymphoma cells and mediates anti-angiogenic, antitumor effects in T-cell lymphoma bearing Swiss albino mice. Arabian Journal of Chemistry 2022;15:103760. [DOI: 10.1016/j.arabjc.2022.103760] [Reference Citation Analysis]
93 Zerbib E, Arif T, Shteinfer-Kuzmine A, Chalifa-Caspi V, Shoshan-Barmatz V. VDAC1 Silencing in Cancer Cells Leads to Metabolic Reprogramming That Modulates Tumor Microenvironment. Cancers (Basel) 2021;13:2850. [PMID: 34200480 DOI: 10.3390/cancers13112850] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
94 Kim S, Ko J, Lee SR, Park D, Park S, Jeon NL. Anchor-IMPACT: A standardized microfluidic platform for high-throughput antiangiogenic drug screening. Biotechnol Bioeng 2021;118:2524-35. [PMID: 33764506 DOI: 10.1002/bit.27765] [Reference Citation Analysis]
95 Liu J, Liu Y, Gong W, Kong X, Wang C, Wang S, Liu A. Prognostic value of insulin-like growth factor 2 mRNA-binding protein 3 and vascular endothelial growth factor-A in patients with primary non-small-cell lung cancer. Oncol Lett 2019;18:4744-52. [PMID: 31611984 DOI: 10.3892/ol.2019.10835] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
96 Kwon JJ, Factora TD, Dey S, Kota J. A Systematic Review of miR-29 in Cancer. Mol Ther Oncolytics 2019;12:173-94. [PMID: 30788428 DOI: 10.1016/j.omto.2018.12.011] [Cited by in Crossref: 65] [Cited by in F6Publishing: 65] [Article Influence: 16.3] [Reference Citation Analysis]
97 Nafar S, Nouri N, Alipour M, Fallahi J, Zare F, Tabei SMB. Exosome as a target for cancer treatment. J Investig Med 2022:jim-2021-002194. [PMID: 35210328 DOI: 10.1136/jim-2021-002194] [Reference Citation Analysis]
98 Sabit H, Cevik E, Tombuloglu H, Abdel-Ghany S, Tombuloglu G, Esteller M. Triple negative breast cancer in the era of miRNA. Crit Rev Oncol Hematol 2021;157:103196. [PMID: 33307198 DOI: 10.1016/j.critrevonc.2020.103196] [Cited by in Crossref: 5] [Cited by in F6Publishing: 1] [Article Influence: 2.5] [Reference Citation Analysis]
99 Uttarawichien T, Kamnerdnond C, Inwisai T, Suwannalert P, Sibmooh N, Payuhakrit W. Quercetin Inhibits Colorectal Cancer Cells Induced-Angiogenesis in Both Colorectal Cancer Cell and Endothelial Cell through Downregulation of VEGF-A/VEGFR2. Sci Pharm 2021;89:23. [DOI: 10.3390/scipharm89020023] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
100 Mottaghi S, Abbaszadeh H. Natural Lignans Honokiol and Magnolol as Potential Anticarcinogenic and Anticancer Agents. A Comprehensive Mechanistic Review. Nutr Cancer 2021;:1-18. [PMID: 34047218 DOI: 10.1080/01635581.2021.1931364] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
101 Zhang H, Ye Q, Du Z, Huang M, Zhang M, Tan H. MiR-148b-3p inhibits renal carcinoma cell growth and pro-angiogenic phenotype of endothelial cell potentially by modulating FGF2. Biomed Pharmacother 2018;107:359-67. [PMID: 30099339 DOI: 10.1016/j.biopha.2018.07.054] [Cited by in Crossref: 11] [Cited by in F6Publishing: 14] [Article Influence: 2.8] [Reference Citation Analysis]
102 Khan U, Shah MA. Ramucirumab for the treatment of gastric or gastro-esophageal junction cancer. Expert Opin Biol Ther 2019;19:1135-41. [PMID: 31452409 DOI: 10.1080/14712598.2019.1656715] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
103 Mottaghi S, Abbaszadeh H. A comprehensive mechanistic insight into the dietary and estrogenic lignans, arctigenin and sesamin as potential anticarcinogenic and anticancer agents. Current status, challenges, and future perspectives. Crit Rev Food Sci Nutr 2021;:1-17. [PMID: 33905270 DOI: 10.1080/10408398.2021.1913568] [Reference Citation Analysis]
104 Abhange K, Makler A, Wen Y, Ramnauth N, Mao W, Asghar W, Wan Y. Small extracellular vesicles in cancer. Bioact Mater 2021;6:3705-43. [PMID: 33898874 DOI: 10.1016/j.bioactmat.2021.03.015] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
105 Fu J, Yu M, Xu W, Yu S. Research Progress of Bile Acids in Cancer. Front Oncol 2022;11:778258. [DOI: 10.3389/fonc.2021.778258] [Reference Citation Analysis]
106 Xiang X, Li L, Bo P, Kuang T, Liu S, Xie X, Guo S, Fu X, Zhang Y. 7‑Difluoromethyl‑5,4'‑dimethoxygenistein exerts anti‑angiogenic effects on acute promyelocytic leukemia HL‑60 cells by inhibiting the TLR4/NF‑κB signaling pathway. Mol Med Rep 2020;21:2251-9. [PMID: 32186776 DOI: 10.3892/mmr.2020.11029] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
107 Ouh YT, Cho HW, Lee JK, Choi SH, Choi HJ, Hong JH. CXC chemokine ligand 1 mediates adiponectin-induced angiogenesis in ovarian cancer. Tumour Biol 2019;42:1010428319842699. [PMID: 30967059 DOI: 10.1177/1010428319842699] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.7] [Reference Citation Analysis]
108 Chandler KB, Costello CE, Rahimi N. Glycosylation in the Tumor Microenvironment: Implications for Tumor Angiogenesis and Metastasis. Cells 2019;8:E544. [PMID: 31195728 DOI: 10.3390/cells8060544] [Cited by in Crossref: 21] [Cited by in F6Publishing: 23] [Article Influence: 7.0] [Reference Citation Analysis]
109 Sajida, Prabhu A. Anti-angiogenic, apoptotic and matrix metalloproteinase inhibitory activity of Withania somnifera (ashwagandha) on lung adenocarcinoma cells. Phytomedicine 2021;90:153639. [PMID: 34280829 DOI: 10.1016/j.phymed.2021.153639] [Reference Citation Analysis]
110 Fang T, Xiao J, Zhang Y, Hu H, Zhu Y, Cheng Y. Combined with interventional therapy, immunotherapy can create a new outlook for tumor treatment. Quant Imaging Med Surg 2021;11:2837-60. [PMID: 34079746 DOI: 10.21037/qims-20-173] [Reference Citation Analysis]
111 Xie S, Wang Y, Huang Y, Yang B. Mechanisms of the antiangiogenic effects of aspirin in cancer. Eur J Pharmacol 2021;898:173989. [PMID: 33657423 DOI: 10.1016/j.ejphar.2021.173989] [Reference Citation Analysis]
112 Plummer C, Michael A, Shaikh G, Stewart M, Buckley L, Miles T, Ograbek A, McCormack T. Expert recommendations on the management of hypertension in patients with ovarian and cervical cancer receiving bevacizumab in the UK. Br J Cancer 2019;121:109-16. [PMID: 31182765 DOI: 10.1038/s41416-019-0481-y] [Cited by in Crossref: 16] [Cited by in F6Publishing: 13] [Article Influence: 5.3] [Reference Citation Analysis]
113 Huda MN, Nurunnabi M. Potential Application of Exosomes in Vaccine Development and Delivery. Pharm Res 2022. [PMID: 35028802 DOI: 10.1007/s11095-021-03143-4] [Reference Citation Analysis]
114 Quintero-Fabián S, Arreola R, Becerril-Villanueva E, Torres-Romero JC, Arana-Argáez V, Lara-Riegos J, Ramírez-Camacho MA, Alvarez-Sánchez ME. Role of Matrix Metalloproteinases in Angiogenesis and Cancer. Front Oncol 2019;9:1370. [PMID: 31921634 DOI: 10.3389/fonc.2019.01370] [Cited by in Crossref: 125] [Cited by in F6Publishing: 126] [Article Influence: 41.7] [Reference Citation Analysis]
115 Dias TR, Santos JMO, Gil da Costa RM, Medeiros R. Long non-coding RNAs regulate the hallmarks of cancer in HPV-induced malignancies. Crit Rev Oncol Hematol 2021;161:103310. [PMID: 33781867 DOI: 10.1016/j.critrevonc.2021.103310] [Reference Citation Analysis]
116 Chan Y, Ng SW, Xin Tan JZ, Gupta G, Tambuwala MM, Bakshi HA, Dureja H, Dua K, Ishaq M, Caruso V, Chellappan DK. Emerging therapeutic potential of the iridoid molecule, asperuloside: A snapshot of its underlying molecular mechanisms. Chemico-Biological Interactions 2020;315:108911. [DOI: 10.1016/j.cbi.2019.108911] [Cited by in Crossref: 10] [Cited by in F6Publishing: 6] [Article Influence: 5.0] [Reference Citation Analysis]
117 Park SH, Kim M, Lee S, Jung W, Kim B. Therapeutic Potential of Natural Products in Treatment of Cervical Cancer: A Review. Nutrients 2021;13:E154. [PMID: 33466408 DOI: 10.3390/nu13010154] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 5.0] [Reference Citation Analysis]
118 Bazzichetto C, Conciatori F, Falcone I, Ciuffreda L. Translational Landscape of mTOR Signaling in Integrating Cues Between Cancer and Tumor Microenvironment. Adv Exp Med Biol 2020;1223:69-80. [PMID: 32030685 DOI: 10.1007/978-3-030-35582-1_4] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
119 Zheng S, Zhang Z, Ding N, Sun J, Lin Y, Chen J, Zhong J, Shao L, Lin Z, Xue M. Identification of the angiogenesis related genes for predicting prognosis of patients with gastric cancer. BMC Gastroenterol 2021;21:146. [PMID: 33794777 DOI: 10.1186/s12876-021-01734-4] [Reference Citation Analysis]
120 Fu C, Xin J, Zhang W, Lai J, Huang Z. LINC00992 exerts oncogenic activities in prostate cancer via regulation of SOX4. Exp Cell Res 2021;408:112855. [PMID: 34599930 DOI: 10.1016/j.yexcr.2021.112855] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
121 De Zutter A, Crijns H, Berghmans N, García-Caballero M, Vanbrabant L, Pörtner N, Vanheule V, Verscheure P, Siddiquei MM, Abu El-Asrar AM, Carmeliet P, Van Wielendaele P, De Meester I, Van Damme J, Proost P, Struyf S. The Chemokine-Based Peptide, CXCL9(74-103), Inhibits Angiogenesis by Blocking Heparan Sulfate Proteoglycan-Mediated Signaling of Multiple Endothelial Growth Factors. Cancers (Basel) 2021;13:5090. [PMID: 34680238 DOI: 10.3390/cancers13205090] [Reference Citation Analysis]
122 Yao F, Zhang L, Jiang G, Liu M, Liang G, Yuan Q. Osthole attenuates angiogenesis in an orthotopic mouse model of hepatocellular carcinoma via the downregulation of nuclear factor-κB and vascular endothelial growth factor. Oncol Lett 2018;16:4471-9. [PMID: 30214582 DOI: 10.3892/ol.2018.9213] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
123 Friedman JR, Richbart SD, Merritt JC, Brown KC, Denning KL, Tirona MT, Valentovic MA, Miles SL, Dasgupta P. Capsaicinoids: Multiple effects on angiogenesis, invasion and metastasis in human cancers. Biomed Pharmacother 2019;118:109317. [PMID: 31404777 DOI: 10.1016/j.biopha.2019.109317] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 3.7] [Reference Citation Analysis]
124 Gabryanczyk A, Klimczak S, Szymczak-Pajor I, Śliwińska A. Is Vitamin D Deficiency Related to Increased Cancer Risk in Patients with Type 2 Diabetes Mellitus? Int J Mol Sci 2021;22:6444. [PMID: 34208589 DOI: 10.3390/ijms22126444] [Reference Citation Analysis]
125 Wen HC, Huo YN, Chou CM, Lee WS. PMA inhibits endothelial cell migration through activating the PKC-δ/Syk/NF-κB-mediated up-regulation of Thy-1. Sci Rep 2018;8:16247. [PMID: 30389973 DOI: 10.1038/s41598-018-34548-8] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 2.0] [Reference Citation Analysis]
126 Zhong L, Li Y, Xiong L, Wang W, Wu M, Yuan T, Yang W, Tian C, Miao Z, Wang T, Yang S. Small molecules in targeted cancer therapy: advances, challenges, and future perspectives. Signal Transduct Target Ther 2021;6:201. [PMID: 34054126 DOI: 10.1038/s41392-021-00572-w] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
127 Hassan RA, Emam SH, Hwang D, Kim GD, Hassanin SO, Khalil MG, Abdou AM, Sonousi A. Design, synthesis and evaluation of anticancer activity of new pyrazoline derivatives by down-regulation of VEGF: Molecular docking and apoptosis inducing activity. Bioorg Chem 2022;118:105487. [PMID: 34798455 DOI: 10.1016/j.bioorg.2021.105487] [Reference Citation Analysis]
128 Kumar S, Verma R, Tyagi N, Gangenahalli G, Verma YK. Therapeutics effect of mesenchymal stromal cells in reactive oxygen species-induced damages. Hum Cell 2021. [PMID: 34800267 DOI: 10.1007/s13577-021-00646-5] [Reference Citation Analysis]
129 Scutti JAB. Importance of immune monitoring approaches and the use of immune checkpoints for the treatment of diffuse intrinsic pontine glioma: From bench to clinic and vice versa (Review). Int J Oncol 2018;52:1041-56. [PMID: 29484440 DOI: 10.3892/ijo.2018.4283] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
130 Fontana F, Limonta P. Dissecting the Hormonal Signaling Landscape in Castration-Resistant Prostate Cancer. Cells 2021;10:1133. [PMID: 34067217 DOI: 10.3390/cells10051133] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
131 Macașoi I, Pavel IZ, Moacă AE, Avram Ș, David VL, Coricovac D, Mioc A, Spandidos DA, Tsatsakis A, Șoica C, Dumitrașcu V, Dehelean C. Mechanistic investigations of antitumor activity of a Rhodamine B‑oleanolic acid derivative bioconjugate. Oncol Rep 2020;44:1169-83. [PMID: 32705265 DOI: 10.3892/or.2020.7666] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
132 Van Petten de Vasconcelos Azevedo F, Lopes DS, Zóia MAP, Correia LIV, Saito N, Fonseca BB, Polloni L, Teixeira SC, Goulart LR, de Melo Rodrigues Ávila V. A New Approach to Inhibiting Triple-Negative Breast Cancer: In Vitro, Ex Vivo and In Vivo Antiangiogenic Effect of BthTx-II, a PLA2-Asp-49 from Bothrops jararacussu Venom. Biomolecules 2022;12:258. [DOI: 10.3390/biom12020258] [Reference Citation Analysis]
133 Zhu J, Tang B, Li J, Shi Y, Chen M, Lv X, Meng M, Weng Q, Zhang N, Fan K, Xu M, Ji J. Identification and validation of the angiogenic genes for constructing diagnostic, prognostic, and recurrence models for hepatocellular carcinoma. Aging (Albany NY) 2020;12:7848-73. [PMID: 32379058 DOI: 10.18632/aging.103107] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
134 Shao C, Huang Y, Fu B, Pan S, Zhao X, Zhang N, Wang W, Zhang Z, Qiu Y, Wang R, Jin M, Kong D. Targeting c-Jun in A549 Cancer Cells Exhibits Antiangiogenic Activity In Vitro and In Vivo Through Exosome/miRNA-494-3p/PTEN Signal Pathway. Front Oncol 2021;11:663183. [PMID: 33898323 DOI: 10.3389/fonc.2021.663183] [Reference Citation Analysis]
135 Wu S, Lu L, Zhou J, Ran D, Wang S, Xu Q, Xu W, Wang J, Liu Y, Xie C, Luo Z, Lu W. All-stage targeted therapy for glioblastoma based on lipid membrane coated cabazitaxel nanocrystals. J Control Release 2022:S0168-3659(22)00181-X. [PMID: 35346767 DOI: 10.1016/j.jconrel.2022.03.047] [Reference Citation Analysis]
136 Esser AK, Ross MH, Fontana F, Su X, Gabay A, Fox GC, Xu Y, Xiang J, Schmieder AH, Yang X, Cui G, Scott M, Achilefu S, Chauhan J, Fletcher S, Lanza GM, Weilbaecher KN. Nanotherapy delivery of c-myc inhibitor targets Protumor Macrophages and preserves Antitumor Macrophages in Breast Cancer. Theranostics 2020;10:7510-26. [PMID: 32685002 DOI: 10.7150/thno.44523] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 2.5] [Reference Citation Analysis]
137 Wehbe R, Frangieh J, Rima M, El Obeid D, Sabatier JM, Fajloun Z. Bee Venom: Overview of Main Compounds and Bioactivities for Therapeutic Interests. Molecules 2019;24:E2997. [PMID: 31430861 DOI: 10.3390/molecules24162997] [Cited by in Crossref: 51] [Cited by in F6Publishing: 38] [Article Influence: 17.0] [Reference Citation Analysis]
138 Shimazu K, Inoue M, Sugiyama S, Fukuda K, Yoshida T, Taguchi D, Uehara Y, Kuriyama S, Tanaka M, Miura M, Nanjyo H, Iwabuchi Y, Shibata H. Curcumin analog, GO-Y078, overcomes resistance to tumor angiogenesis inhibitors. Cancer Sci 2018;109:3285-93. [PMID: 30024080 DOI: 10.1111/cas.13741] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
139 Parmar D, Apte M. Angiopoietin inhibitors: A review on targeting tumor angiogenesis. Eur J Pharmacol 2021;899:174021. [PMID: 33741382 DOI: 10.1016/j.ejphar.2021.174021] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
140 Sanidas E, Papadopoulos DP, Velliou M, Tsioufis K, Mantzourani M, Iliopoulos D, Perrea D, Barbetseas J, Papademetriou V. The Role of Angiogenesis Inhibitors in Hypertension: Following "Ariadne's Thread". Am J Hypertens 2018;31:961-9. [PMID: 29788148 DOI: 10.1093/ajh/hpy087] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
141 Bijelic A, Aureliano M, Rompel A. Im Kampf gegen Krebs: Polyoxometallate als nächste Generation metallhaltiger Medikamente. Angew Chem 2019;131:3008-29. [DOI: 10.1002/ange.201803868] [Cited by in Crossref: 32] [Cited by in F6Publishing: 14] [Article Influence: 8.0] [Reference Citation Analysis]
142 Dombroski JA, Hope JM, Sarna NS, King MR. Channeling the Force: Piezo1 Mechanotransduction in Cancer Metastasis. Cells 2021;10:2815. [PMID: 34831037 DOI: 10.3390/cells10112815] [Reference Citation Analysis]
143 Adekoya TO, Richardson RM. Cytokines and Chemokines as Mediators of Prostate Cancer Metastasis. Int J Mol Sci 2020;21:E4449. [PMID: 32585812 DOI: 10.3390/ijms21124449] [Cited by in Crossref: 13] [Cited by in F6Publishing: 16] [Article Influence: 6.5] [Reference Citation Analysis]
144 Teleanu RI, Chircov C, Grumezescu AM, Teleanu DM. Tumor Angiogenesis and Anti-Angiogenic Strategies for Cancer Treatment. J Clin Med 2019;9:E84. [PMID: 31905724 DOI: 10.3390/jcm9010084] [Cited by in Crossref: 69] [Cited by in F6Publishing: 63] [Article Influence: 23.0] [Reference Citation Analysis]
145 Osawa Y, Yoshio S, Aoki Y, Korenaga M, Imamura M, Oide T, Okawara M, Kawai H, Tsutsui Y, Yoshida Y, Yoshikawa S, Mori T, Yamazoe T, Kanto T. Blood angiopoietin-2 predicts liver angiogenesis and fibrosis in hepatitis C patients. BMC Gastroenterol 2021;21:55. [PMID: 33557759 DOI: 10.1186/s12876-021-01633-8] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
146 Rodoplu D, Matahum JS, Hsu CH. A microfluidic hanging drop-based spheroid co-culture platform for probing tumor angiogenesis. Lab Chip 2022. [PMID: 35191460 DOI: 10.1039/d1lc01177d] [Reference Citation Analysis]
147 Shoari A, Tahmasebi M, Khodabakhsh F, Cohan RA, Oghalaie A, Behdani M. Angiogenic biomolecules specific nanobodies application in cancer imaging and therapy; review and updates. International Immunopharmacology 2022;105:108585. [DOI: 10.1016/j.intimp.2022.108585] [Reference Citation Analysis]
148 Moreno JD, Papageorgiou G, Gazouli I, Kyriazoglou A. Systemic Treatment of Ewing Sarcoma: Current Options and Future Perspectives. Forum of Clinical Oncology 2022;0. [DOI: 10.2478/fco-2021-0005] [Reference Citation Analysis]
149 Manolis AA, Manolis TA, Mikhailidis DP, Manolis AS. Cardiovascular safety of oncologic agents: a double-edged sword even in the era of targeted therapies - Part 2. Expert Opin Drug Saf 2018;17:893-915. [PMID: 30126303 DOI: 10.1080/14740338.2018.1513489] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
150 Gong L, Zhou X, Sun J. Circular RNAs Interaction with MiRNAs: Emerging Roles in Breast Cancer. Int J Med Sci 2021;18:3182-96. [PMID: 34400888 DOI: 10.7150/ijms.62219] [Reference Citation Analysis]
151 Xu M, Wang Y, Xia R, Wei Y, Wei X. Role of the CCL2-CCR2 signalling axis in cancer: Mechanisms and therapeutic targeting. Cell Prolif 2021;54:e13115. [PMID: 34464477 DOI: 10.1111/cpr.13115] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
152 Muro K, Salinardi T, Singh AR, Macarulla T. Safety of Aflibercept in Metastatic Colorectal Cancer: A Literature Review and Expert Perspective on Clinical and Real-World Data. Cancers (Basel) 2020;12:E844. [PMID: 32244546 DOI: 10.3390/cancers12040844] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
153 Hay BA, Godugu K, Darwish NHE, Fujioka K, Sudha T, Karakus OO, Mousa SA. New Thyrointegrin αvβ3 Antagonist with a Scalable Synthesis, Brain Penetration, and Potent Activity against Glioblastoma Multiforme. J Med Chem 2021;64:6300-9. [PMID: 33886292 DOI: 10.1021/acs.jmedchem.1c00350] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
154 Zhang LY, Zhang JG, Yang X, Cai MH, Zhang CW, Hu ZM. Targeting Tumor Immunosuppressive Microenvironment for the Prevention of Hepatic Cancer: Applications of Traditional Chinese Medicines in Targeted Delivery. Curr Top Med Chem 2020;20:2789-800. [PMID: 33076809 DOI: 10.2174/1568026620666201019111524] [Reference Citation Analysis]
155 Ramirez MF, Gorur A, Cata JP. The role of opioids in cancer progression. Int Anesthesiol Clin 2020;58:57-63. [PMID: 32011351 DOI: 10.1097/AIA.0000000000000268] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
156 Rajabi M, Adeyeye M, Mousa SA. Peptide-Conjugated Nanoparticles as Targeted Anti-angiogenesis Therapeutic and Diagnostic in Cancer. CMC 2019;26:5664-83. [DOI: 10.2174/0929867326666190620100800] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
157 Tsai Y, Sung L, Haw W, Chen C, Huang S, Liu J, Cheng T, Chen P, Loh S, Tsai C. Cafestol, a coffee diterpene, inhibits urotensin II-induced interleukin-8 expression in human umbilical vein endothelial cells. European Journal of Pharmacology 2018;820:106-12. [DOI: 10.1016/j.ejphar.2017.12.030] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 2.3] [Reference Citation Analysis]
158 Comandone A, Vana F, Comandone T, Tucci M. Antiangiogenic Therapy in Clear Cell Renal Carcinoma (CCRC): Pharmacological Basis and Clinical Results. Cancers (Basel) 2021;13:5896. [PMID: 34885006 DOI: 10.3390/cancers13235896] [Reference Citation Analysis]
159 Farhan M, Silva M, Xingan X, Huang Y, Zheng W. Role of FOXO Transcription Factors in Cancer Metabolism and Angiogenesis. Cells 2020;9:E1586. [PMID: 32629884 DOI: 10.3390/cells9071586] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
160 Tavares WR, Seca AML. Inula L. Secondary Metabolites against Oxidative Stress-Related Human Diseases. Antioxidants (Basel) 2019;8:E122. [PMID: 31064136 DOI: 10.3390/antiox8050122] [Cited by in Crossref: 21] [Cited by in F6Publishing: 14] [Article Influence: 7.0] [Reference Citation Analysis]
161 Ngema LM, Adeyemi SA, Marimuthu T, Choonara YE. A review on engineered magnetic nanoparticles in Non-Small-Cell lung carcinoma targeted therapy. Int J Pharm 2021;606:120870. [PMID: 34245844 DOI: 10.1016/j.ijpharm.2021.120870] [Reference Citation Analysis]
162 Ravi S, Alencar AM, Arakelyan J, Xu W, Stauber R, Wang CI, Papyan R, Ghazaryan N, Pereira RM. An Update to Hallmarks of Cancer. Cureus. [DOI: 10.7759/cureus.24803] [Reference Citation Analysis]
163 Mauro A, Berardinelli P, Russo V, Bernabò N, Martelli A, Nardinocchi D, Di Giacinto O, Turriani M, Barboni B. Effects of P4 Antagonist RU486 on VEGF and Its Receptors' Signaling during the In Vivo Transition from the Preovulatory to Periovulatory Phase of Ovarian Follicles. Int J Mol Sci 2021;22:13520. [PMID: 34948315 DOI: 10.3390/ijms222413520] [Reference Citation Analysis]
164 Tirpe A, Gulei D, Tirpe GR, Nutu A, Irimie A, Campomenosi P, Pop LA, Berindan-Neagoe I. Beyond Conventional: The New Horizon of Anti-Angiogenic microRNAs in Non-Small Cell Lung Cancer Therapy. Int J Mol Sci 2020;21:E8002. [PMID: 33121202 DOI: 10.3390/ijms21218002] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
165 Vorontsova A, Kan T, Raviv Z, Shaked Y. The Dichotomous Role of Bone Marrow Derived Cells in the Chemotherapy-Treated Tumor Microenvironment. J Clin Med 2020;9:E3912. [PMID: 33276524 DOI: 10.3390/jcm9123912] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
166 Trusler O, Goodwin J, Laslett AL. BRCA1 and BRCA2 associated breast cancer and the roles of current modelling systems in drug discovery. Biochim Biophys Acta Rev Cancer 2021;1875:188459. [PMID: 33129865 DOI: 10.1016/j.bbcan.2020.188459] [Reference Citation Analysis]
167 Rossi A. New options for combination therapy for advanced non-squamous NSCLC. Expert Rev Respir Med 2019;13:1095-107. [PMID: 31512526 DOI: 10.1080/17476348.2019.1667233] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.7] [Reference Citation Analysis]
168 Hersh J, Broyles D, Capcha JMC, Dikici E, Shehadeh LA, Daunert S, Deo S. Peptide-Modified Biopolymers for Biomedical Applications. ACS Appl Bio Mater 2021;4:229-51. [PMID: 34250454 DOI: 10.1021/acsabm.0c01145] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
169 Chao YH, Wu KH, Yeh CM, Su SC, Reiter RJ, Yang SF. The potential utility of melatonin in the treatment of childhood cancer. J Cell Physiol 2019;234:19158-66. [PMID: 30945299 DOI: 10.1002/jcp.28566] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
170 Spagnuolo A, Palazzolo G, Sementa C, Gridelli C. Vascular endothelial growth factor receptor tyrosine kinase inhibitors for the treatment of advanced non-small cell lung cancer. Expert Opinion on Pharmacotherapy 2020;21:491-506. [DOI: 10.1080/14656566.2020.1713092] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
171 Li Y, Liu Q, Tian J, He H, Luo W. Angiogenesis Process in Osteosarcoma: An Updated Perspective of Pathophysiology and Therapeutics. The American Journal of the Medical Sciences 2019;357:280-8. [DOI: 10.1016/j.amjms.2018.12.004] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 3.3] [Reference Citation Analysis]
172 Dobbin SJH, Petrie MC, Myles RC, Touyz RM, Lang NN. Cardiotoxic effects of angiogenesis inhibitors. Clin Sci (Lond) 2021;135:71-100. [PMID: 33404052 DOI: 10.1042/CS20200305] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
173 Forma E, Bryś M. Anticancer Activity of Propolis and Its Compounds. Nutrients 2021;13:2594. [PMID: 34444754 DOI: 10.3390/nu13082594] [Reference Citation Analysis]
174 Hsu PC, Huang CY, Wang CC, Kuo SC, Chu CH, Tung PH, Huang AC, Wang CL, Chiu LC, Fang YF, Yang CT. The Combination of Afatinib and Bevacizumab in Untreated EGFR-Mutated Advanced Lung Adenocarcinoma: A Multicenter Observational Study. Pharmaceuticals (Basel) 2020;13:E331. [PMID: 33113888 DOI: 10.3390/ph13110331] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
175 Lilburn DM, Groves AM. The role of PET in imaging of the tumour microenvironment and response to immunotherapy. Clinical Radiology 2021;76:784.e1-784.e15. [DOI: 10.1016/j.crad.2021.08.004] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
176 Yang T, Jiang YX, Wu Y, Lu D, Huang R, Wang LL, Wang SQ, Guan YY, Zhang H, Luan X. Resibufogenin Suppresses Triple-Negative Breast Cancer Angiogenesis by Blocking VEGFR2-Mediated Signaling Pathway. Front Pharmacol 2021;12:682735. [PMID: 33995111 DOI: 10.3389/fphar.2021.682735] [Reference Citation Analysis]
177 Esteves M, Monteiro MP, Duarte JA. Role of Regular Physical Exercise in Tumor Vasculature: Favorable Modulator of Tumor Milieu. Int J Sports Med 2021;42:389-406. [PMID: 33307553 DOI: 10.1055/a-1308-3476] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
178 Oh IH, Pyo JS, Son BK. Prognostic Impact of YKL-40 Immunohistochemical Expression in Patients with Colorectal Cancer. Curr Oncol 2021;28:3139-49. [PMID: 34436040 DOI: 10.3390/curroncol28040274] [Reference Citation Analysis]
179 Nguyen HM, Guz-Montgomery K, Saha D. Oncolytic Virus Encoding a Master Pro-Inflammatory Cytokine Interleukin 12 in Cancer Immunotherapy. Cells 2020;9:E400. [PMID: 32050597 DOI: 10.3390/cells9020400] [Cited by in Crossref: 18] [Cited by in F6Publishing: 18] [Article Influence: 9.0] [Reference Citation Analysis]
180 Nifosì AF, Zuccarello M, Nifosì L, Hervas Saus V, Nifosì G. Osteonecrosis of the jaw in the era of targeted therapy and immunotherapy in oncology. J Korean Assoc Oral Maxillofac Surg 2019;45:3-8. [PMID: 30847290 DOI: 10.5125/jkaoms.2019.45.1.3] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 2.7] [Reference Citation Analysis]
181 Hu M, Varier KM, Li Z, Qin X, Rao Q, Song J, Hu A, Hang Y, Yuan C, Gajendran B, Shu L, Wen M, Li Y, Liu H. A natural acylphloroglucinol triggered antiproliferative possessions in HEL cells by impeding STAT3 signaling and attenuating angiogenesis in transgenic zebrafish model. Biomed Pharmacother 2021;141:111877. [PMID: 34323693 DOI: 10.1016/j.biopha.2021.111877] [Reference Citation Analysis]
182 Huda MN, Nafiujjaman M, Deaguero IG, Okonkwo J, Hill ML, Kim T, Nurunnabi M. Potential Use of Exosomes as Diagnostic Biomarkers and in Targeted Drug Delivery: Progress in Clinical and Preclinical Applications. ACS Biomater Sci Eng 2021;7:2106-49. [PMID: 33988964 DOI: 10.1021/acsbiomaterials.1c00217] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
183 Malapelle U, Rossi A. Emerging angiogenesis inhibitors for non-small cell lung cancer. Expert Opinion on Emerging Drugs 2019;24:71-81. [DOI: 10.1080/14728214.2019.1619696] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
184 Wu XY, Zhu YM, Qi Y, Xu WW, Jing-Zhai. Erythropoietin, as a biological macromolecule in modification of tissue engineered constructs: A review. Int J Biol Macromol 2021:S0141-8130(21)02463-6. [PMID: 34793816 DOI: 10.1016/j.ijbiomac.2021.11.065] [Reference Citation Analysis]
185 Cui J, Liu Y, Wang X. The Roles of Glycodelin in Cancer Development and Progression. Front Immunol 2017;8:1685. [PMID: 29238349 DOI: 10.3389/fimmu.2017.01685] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 2.4] [Reference Citation Analysis]
186 Advani D, Gupta R, Tripathi R, Sharma S, Ambasta RK, Kumar P. Protective role of anticancer drugs in neurodegenerative disorders: A drug repurposing approach. Neurochem Int 2020;140:104841. [PMID: 32853752 DOI: 10.1016/j.neuint.2020.104841] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
187 Nakayama J, Makinoshima H. Zebrafish-Based Screening Models for the Identification of Anti-Metastatic Drugs. Molecules 2020;25:E2407. [PMID: 32455810 DOI: 10.3390/molecules25102407] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
188 Jayachandran M, Chung SSM, Xu B. A critical review of the relationship between dietary components, the gut microbe Akkermansia muciniphila , and human health. Critical Reviews in Food Science and Nutrition 2020;60:2265-76. [DOI: 10.1080/10408398.2019.1632789] [Cited by in Crossref: 17] [Cited by in F6Publishing: 15] [Article Influence: 5.7] [Reference Citation Analysis]
189 Fakhri S, Abbaszadeh F, Jorjani M, Pourgholami MH. The effects of anticancer medicinal herbs on vascular endothelial growth factor based on pharmacological aspects: a review study. Nutrition and Cancer 2021;73:1-15. [DOI: 10.1080/01635581.2019.1673451] [Cited by in Crossref: 7] [Cited by in F6Publishing: 9] [Article Influence: 2.3] [Reference Citation Analysis]
190 Almahmoudi R, Salem A, Murshid S, Dourado MR, Apu EH, Salo T, Al-Samadi A. Interleukin-17F Has Anti-Tumor Effects in Oral Tongue Cancer. Cancers (Basel) 2019;11:E650. [PMID: 31083515 DOI: 10.3390/cancers11050650] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]